Focused on the development & commercialization of innovative medicines in the areas of cancer prevention & treatment. Evaluates its products for other potential therapeutic applications beyond oncology, & works to expand upon its product development pipeline through its in-house R&D efforts & potential mergers & acquisition activities. Core business strategy is to commercialize the drug products we develop on a royalty-bearing basis via third-party licensing arrangements.